​

National Health Investors (NHI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NHI Stock Forecast

National Health Investors (NHI) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $72.20, with a high of $92.00 and a low of $61.00. This represents a -4.71% decline from the last price of $75.77.

$55 $63 $71 $79 $87 $95 High: $92 Avg: $72.2 Low: $61 Last Closed Price: $75.77

NHI Stock Rating

National Health Investors stock's rating consensus is Hold, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (26.67%), 11 Hold (73.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 15 0 11 4 Strong Sell Sell Hold Buy Strong Buy

NHI Price Target Upside V Benchmarks

TypeNameUpside
StockNational Health Investors-4.71%
SectorReal Estate Stocks 18.32%
IndustryHealthcare REIT Stocks16.83%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$85.00
Last Closing Price$75.77$75.77$75.77
Upside/Downside--12.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25134--8
Mar, 25134--8
Feb, 25134--8
Jan, 25134--8
Dec, 24134--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 24, 2024Joshua DennerleinBank of America Securities$92.00$84.718.61%21.42%
Aug 30, 2024Michael LewisTruist Financial$78.00$80.74-3.39%2.94%
Apr 03, 2024Michael LewisTruist Financial$58.00$59.89-3.16%-23.45%
Mar 12, 2024John KimNational Bank$67.00$59.5612.49%-11.57%
Feb 26, 2024Connor SiverskyWells Fargo$63.00$57.769.07%-16.85%
Dec 09, 2022Tayo OkusanyaNational Bank$58.00$56.542.58%-23.45%
Sep 26, 2022Truist Financial$61.00$55.4410.03%-19.49%
Apr 18, 2022John KimBMO Capital$61.00$54.5911.74%-19.49%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 01, 2024Wells FargoOverweightEqual-Weightdowngrade
Sep 24, 2024Bank of America SecuritiesBuyinitialise
Aug 23, 2024Wells FargoOverweightOverweighthold
Apr 19, 2024BMO CapitalOutperformOutperformhold
Mar 19, 2024WedbushOutperformNeutraldowngrade
Mar 12, 2024BMO CapitalMarket PerformOutperformupgrade
Feb 26, 2024Wells FargoEqual-WeightOverweightupgrade
Dec 01, 2023Wells FargoEqual-WeightEqual-Weighthold
Dec 09, 2022Credit SuisseNeutralupgrade
Jun 21, 2022BMO CapitalMarket Performdowngrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.03$1.36$0.52$3.13$3.14----
Avg Forecast$4.30$3.11$2.17$3.07$2.91$3.14$3.34$3.36-
High Forecast$5.00$3.62$2.68$3.08$2.94$3.22$3.45$4.39-
Low Forecast$3.91$2.83$1.95$3.05$2.90$3.09$3.28$2.93-
Surprise %-29.53%-56.27%-76.04%1.95%7.90%----

Revenue Forecast

$200M $240M $280M $320M $360M $400M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$332.81M$298.71M$278.19M$319.83M$257.05M----
Avg Forecast$314.79M$288.95M$226.00M$259.99M$267.97M$279.05M$279.18M$258.41M$259.53M
High Forecast$354.43M$325.34M$266.57M$261.54M$277.23M$341.33M$344.73M$319.09M$320.47M
Low Forecast$292.97M$268.93M$208.19M$259.39M$254.76M$250.87M$251.75M$233.03M$234.04M
Surprise %5.73%3.38%23.10%23.02%-4.08%----

Net Income Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$135.37M$62.19M$23.06M$135.65M$137.87M----
Avg Forecast$168.07M$132.59M$98.03M$135.60M$126.68M$136.94M$146.20M$168.09M-
High Forecast$201.68M$159.11M$117.64M$162.72M$127.52M$139.86M$149.90M$190.29M-
Low Forecast$134.45M$106.07M$78.43M$108.48M$125.80M$134.01M$142.49M$127.17M-
Surprise %-19.45%-53.10%-76.48%0.04%8.83%----

NHI Forecast FAQ

Is National Health Investors stock a buy?

National Health Investors stock has a consensus rating of Hold, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 11 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that National Health Investors is a neutral investment for most analysts.

What is National Health Investors's price target?

National Health Investors's price target, set by 15 Wall Street analysts, averages $72.2 over the next 12 months. The price target range spans from $61 at the low end to $92 at the high end, suggesting a potential -4.71% change from the previous closing price of $75.77.

How does National Health Investors stock forecast compare to its benchmarks?

National Health Investors's stock forecast shows a -4.71% downside, underperforming the average forecast for the real estate stocks sector (18.32%) and underperforming the healthcare reit stocks industry (16.83%).

What is the breakdown of analyst ratings for National Health Investors over the past three months?

  • April 2025: 12.50% Strong Buy, 37.50% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 12.50% Strong Buy, 37.50% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 12.50% Strong Buy, 37.50% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is National Health Investors’s EPS forecast?

National Health Investors's average annual EPS forecast for its fiscal year ending in December 2025 is $3.14, marking a 0% decrease from the reported $3.14 in 2024. Estimates for the following years are $3.34 in 2026, $3.36 in 2027, and $0 in 2028.

What is National Health Investors’s revenue forecast?

National Health Investors's average annual revenue forecast for its fiscal year ending in December 2025 is $279.05M, reflecting a 8.56% increase from the reported $257.05M in 2024. The forecast for 2026 is $279.18M, followed by $258.41M for 2027, and $259.53M for 2028.

What is National Health Investors’s net income forecast?

National Health Investors's net income forecast for the fiscal year ending in December 2025 stands at $136.94M, representing a -0.67% decrease from the reported $137.87M in 2024. Projections indicate $146.2M in 2026, $168.09M in 2027, and $0 in 2028.